| Literature DB >> 28391169 |
Guangyuan Zhang1, Yu Yang1, Yeqing Huang1, Lei Zhang1, Zhixin Ling1, Yingjian Zhu2, Feng Wang3, Xiangyu Zou4, Ming Chen5.
Abstract
Remote ischemic preconditioning (rIPC) is a reliable strategy for prevention of injury to various organs. However the mechanism by which it does so is still unclear. In the present study, serum and EVs isolated from ischemic preconditioned right renal venous perfusates were injected into rats with ischemia-reperfusion-injured kidneys immediately after reperfusion. The animals were killed 24h later. Tubular scores and renal function were tested to evaluate the therapeutic effects. To further explore the underlying mechanism, HK-2 cells derived EVs under hypoxia were also administrated to rats with left kidney IRI. Results showed that transient ischemia of the right kidney induced renal tubular epithelial cells to release functional extracellular vesicles (EVs), which were found to alleviate left kidney ischemic reperfusion injury (IRI) by circulation and the EV-depleted serum lost this property. Further, human kidney cells (HK2) were cultured under hypoxic conditions to generate EVs in vitro. These EVs also showed obvious therapeutic effects for renal IRI. Our results suggested that remote ischemic preconditioning plays a therapeutic role in renal IRI through EVs induced by hypoxia.Entities:
Keywords: Extracellular vesicles; Hypoxia; Kidney ischemia-reperfusion injury; Remote ischemic preconditioning; Renal tubular epithelial cells
Mesh:
Year: 2017 PMID: 28391169 DOI: 10.1016/j.biopha.2017.03.096
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529